Literature DB >> 22524785

Multiple functions of endocannabinoid signaling in the brain.

István Katona1, Tamás F Freund.   

Abstract

Despite being regarded as a hippie science for decades, cannabinoid research has finally found its well-deserved position in mainstream neuroscience. A series of groundbreaking discoveries revealed that endocannabinoid molecules are as widespread and important as conventional neurotransmitters such as glutamate or GABA, yet they act in profoundly unconventional ways. We aim to illustrate how uncovering the molecular, anatomical, and physiological characteristics of endocannabinoid signaling has revealed new mechanistic insights into several fundamental phenomena in synaptic physiology. First, we summarize unexpected advances in the molecular complexity of biogenesis and inactivation of the two endocannabinoids, anandamide and 2-arachidonoylglycerol. Then, we show how these new metabolic routes are integrated into well-known intracellular signaling pathways. These endocannabinoid-producing signalosomes operate in phasic and tonic modes, thereby differentially governing homeostatic, short-term, and long-term synaptic plasticity throughout the brain. Finally, we discuss how cell type- and synapse-specific refinement of endocannabinoid signaling may explain the characteristic behavioral effects of cannabinoids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524785      PMCID: PMC4273654          DOI: 10.1146/annurev-neuro-062111-150420

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  181 in total

1.  Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons.

Authors:  Attila Losonczy; Agota A Biró; Zoltan Nusser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

2.  The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling.

Authors:  Samir Haj-Dahmane; Roh-Yu Shen
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

3.  Spine Ca2+ signaling in spike-timing-dependent plasticity.

Authors:  Thomas Nevian; Bert Sakmann
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

4.  TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.

Authors:  Helen E Gibson; Jeffrey G Edwards; Rachel S Page; Matthew J Van Hook; Julie A Kauer
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

5.  Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2006-07-03       Impact factor: 5.157

6.  Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism.

Authors:  Jason C Parrish; David E Nichols
Journal:  J Neurochem       Date:  2006-09-29       Impact factor: 5.372

7.  The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish.

Authors:  R Mechoulam; Y Gaoni
Journal:  Tetrahedron Lett       Date:  1967-03       Impact factor: 2.415

8.  Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.

Authors:  Jimok Kim; Masako Isokawa; Catherine Ledent; Bradley E Alger
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

9.  Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

Authors:  Amy C Porter; John-Michael Sauer; Michael D Knierman; Gerald W Becker; Michael J Berna; Jingqi Bao; George G Nomikos; Petra Carter; Frank P Bymaster; Andrea Baker Leese; Christian C Felder
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

10.  Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D.

Authors:  Yong-Xin Sun; Kazuhito Tsuboi; Yasuo Okamoto; Takeharu Tonai; Makoto Murakami; Ichiro Kudo; Natsuo Ueda
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

View more
  199 in total

1.  Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats.

Authors:  Marek Zubrzycki; Anna Janecka; Andreas Liebold; Mechthild Ziegler; Maria Zubrzycka
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

2.  Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity.

Authors:  Yihui Cui; Vincent Paillé; Hao Xu; Stéphane Genet; Bruno Delord; Elodie Fino; Hugues Berry; Laurent Venance
Journal:  J Physiol       Date:  2015-05-13       Impact factor: 5.182

3.  Nonnociceptive afferent activity depresses nocifensive behavior and nociceptive synapses via an endocannabinoid-dependent mechanism.

Authors:  Sharleen Yuan; Brian D Burrell
Journal:  J Neurophysiol       Date:  2013-09-11       Impact factor: 2.714

Review 4.  Small-volume analysis of cell-cell signaling molecules in the brain.

Authors:  Elena V Romanova; Jordan T Aerts; Callie A Croushore; Jonathan V Sweedler
Journal:  Neuropsychopharmacology       Date:  2013-06-10       Impact factor: 7.853

5.  Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.

Authors:  Shi Di; Ion R Popescu; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

Review 6.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

7.  Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain.

Authors:  Amanda J Morgan; Philip J Kingsley; Michelle M Mitchener; Megan Altemus; Toni A Patrick; Andrew D Gaulden; Lawrence J Marnett; Sachin Patel
Journal:  ACS Chem Neurosci       Date:  2018-05-09       Impact factor: 4.418

8.  Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training.

Authors:  Maria Morena; Benno Roozendaal; Viviana Trezza; Patrizia Ratano; Andrea Peloso; Daniela Hauer; Piray Atsak; Luigia Trabace; Vincenzo Cuomo; James L McGaugh; Gustav Schelling; Patrizia Campolongo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 9.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 10.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.